>
Switch to:

Travere Therapeutics Debt-to-Asset

: 0.36 As of Dec. 2020
View and export this data going back to 2003. Start your Free Trial

Travere Therapeutics's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2020 was $0.0 Mil. Travere Therapeutics's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2020 was $215.3 Mil. Travere Therapeutics's Long-Term Debt & Capital Lease ObligationTotal Assets for the quarter that ended in Dec. 2020 was $607.4 Mil. Travere Therapeutics's debt to asset for the quarter that ended in Dec. 2020 was 0.35.


Travere Therapeutics Debt-to-Asset Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.

* Premium members only.

Travere Therapeutics Annual Data
Feb11 Feb12 Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20
Debt-to-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.09 0.09 0.31 0.34 0.36

Travere Therapeutics Quarterly Data
Mar16 Jun16 Sep16 Dec16 Mar17 Jun17 Sep17 Dec17 Mar18 Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20
Debt-to-Asset Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.34 0.36 0.31 0.31 0.36

Competitive Comparison
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap.


Travere Therapeutics Debt-to-Asset Distribution

* The bar in red indicates where Travere Therapeutics's Debt-to-Asset falls into.



Travere Therapeutics Debt-to-Asset Calculation

Debt to Asset measures the financial leverage a company has.

Travere Therapeutics's Debt-to-Asset for the fiscal year that ended in Dec. 2020 is calculated as

Travere Therapeutics's Debt-to-Asset for the quarter that ended in Dec. 2020 is calculated as

* All numbers are in millions except for per share data and ratio. All numbers are in their local exchange's currency.


Travere Therapeutics  (NAS:TVTX) Debt-to-Asset Explanation

In the calculation of Debt-to-Asset, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Assets.


Travere Therapeutics Debt-to-Asset Related Terms


Travere Therapeutics Debt-to-Asset Headlines

No Headline

Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)